Biotechnology Ltd. / Alpha Ltd. / Maureen L. Suda Suda Communications LLC / Bristol-Myers Squibb Company / Modular Antibody Technology / Bristol-Myers Squibb / Twitter / /
Continent
Europe / /
Country
United States / United Kingdom / /
Currency
USD / / /
IndustryTerm
defined / biopharmaceutical / treatment of breast and gastric cancer / cancer therapy / manufacturing / genuine bispecific antibody products / bispecific antibody products / /
MedicalCondition
serious diseases / breast cancers / breast and gastric cancer / cancer / tumors / HER2-positive cancer / gastric cancers / certain HER2-positive cancers / solid tumors / tumour / breast cancer / /
MedicalTreatment
cancer therapy / /
Person
Francis Cuss / John Haurum / Ryan Asay / Jane Dancer / Laura Hortas / Ken Dominski / / /
Position
Chief Executive Officer / Chief Business Officer / dancer / chief executive officer at F- / executive vice president and chief scientific officer / /
Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy (NEW YORK and CAMBRIDGE, UK – October 28, Bristol-Myers Squibb Compa